Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Oktober 2023

Genmab — Oktober 2023

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • V Offline
    V Offline
    Vitus
    wrote on sidst redigeret af
    #120

    Håber da Darzalex patentsagen ender positivt….

    1 Reply Last reply
    0
    • J Offline
      J Offline
      JKY_VH
      wrote on sidst redigeret af
      #121

      Det kan vi da håbe Vitus

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #122

        anything of interest in that medwatch/Novo article?

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #123

          AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC https://www.prnewswire.com/news-releases/amgen-completes-acquisition-of-horizon-therapeutics-plc-301949517.html --> let's start that Tepezza push

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #124

            Rapport fra Stifel omkring situtationen for biotek https://www.proinvestor.com/boards/115979

            1 Reply Last reply
            0
            • P Offline
              P Offline
              peter12
              wrote on sidst redigeret af
              #125

              Lidt om gen3014 h2hhttps://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(23)01668-3/pdf

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #126

                Ja, så mangler vi bare resultaterne. Næsten uudholdeligt spændende. 🙂 Det er ikke store ord, de bruger om de foreløbige resultater: tolerabel sikkerhedsprofil og påvist klinisk aktivitet.

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #127

                  16 mg/kg, det er det samme som IV dara. Så skulle der vel kunne fikses en sc version.

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #128

                    I givet fald.

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #129

                      Tepkinly European public assessment report if you really have nothing to do this weekend https://www.ema.europa.eu/en/medicines/human/EPAR/tepkinly

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        peter12
                        wrote on sidst redigeret af
                        #130

                        We're waiting for a brief summary. What does orphan mean for the drug in this context ?

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #131

                          https://www.ema.europa.eu/en/human-regulatory/overview/orphan-designation-overview
                          https://www.ema.europa.eu/en/human-regulatory/research-development/orphan-designation/orphan-incentives

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            peter12
                            wrote on sidst redigeret af
                            #132

                            Ok thanks,
                            so it still need to be approved before use

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #133

                              epcoritamab has had EMA orphan status since early 2022, it should all be there in those documents somewhere 😉

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                ProinvestorNEWS
                                wrote on sidst redigeret af
                                #134

                                Dagens aktie er AbbVie Inc.

                                AbbVie er en amerikansk børsnoteret biofarmaceutisk virksomhed der opstod som spin-off af Abbott Laboratories
                                62+ mio. mennesker behandles årlig med produkter fra AbbVie på tværs af 60+ sygdomme.
                                Primære områder er Immunologi - Onkologi - Virologi - Neurologi - Æstetik https://www.proinvestor.com/boards/116020

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #135

                                  Eddie Cliff

                                  @Eddie_Cliff
                                  ? ? Exciting sneak peek of some of the first efficacy data of bispecific antibodies in R/R CLL: epcoritamab

                                  • 32% complete responses, ORR 58% https://twitter.com/Eddie_Cliff/status/1711090884094095701
                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #136

                                    Amgen gennemfører købet af Horizon til 200 milliarder kroner
                                    Med handlen får Genmab en ny samarbejdspartner. https://medwatch.dk/Medicinal___Biotek/article16495947.ece?utm_medium=latestNews

                                    1 Reply Last reply
                                    0
                                    • J Offline
                                      J Offline
                                      JKY_VH
                                      wrote on sidst redigeret af
                                      #137

                                      Tak for den E L, en lille god "nyhed" for Genmab.

                                      1 Reply Last reply
                                      0
                                      • J Offline
                                        J Offline
                                        JKY_VH
                                        wrote on sidst redigeret af
                                        #138

                                        I så fald må rente ned "Storbank: Recessionen rammer snart" https://borsen.dk/nyheder/perspektiv/chefokonom-i-storbank-rentestigninger-gor-ondt-nu-recessionen-rammer-snart?b_source=borsen&b_medium=row_1&b_campaign=list_1

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          Klarussen
                                          wrote on sidst redigeret af
                                          #139

                                          Shorts stiger igen i Genmab til 1,08% (fra 0,85 sidst)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper